Cordyceps Sunshine Biotech Holdings RAJAF
OTC RAJAF
$9.18 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Cordyceps Sunshine Biotech Holdings (RAJAF) EBIT (2021 - 2023)

Cordyceps Sunshine Biotech Holdings (RAJAF) posted quarterly EBIT of $120448.0 for Q4 2023, up 426.41% year-over-year from $22881.1 in Q4 2022, and up 426.41% quarter-over-quarter from -$36901.0 in Q4 2022.

Cordyceps Sunshine Biotech Holdings (RAJAF) EBIT (2021 - 2023) Analysis & Trends

Cordyceps Sunshine Biotech Holdings' EBIT history runs 3 years deep, the most recent figure standing at $120448.0 for Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Kraft Heinz 30.23 Bn 27.54 Bn 2.03 Bn -6.43 Bn
2 General Mills 21.36 Bn 20.90 Bn 1.60 Bn -2.09 Bn
3 Mccormick 14.89 Bn 14.56 Bn 778.20 Mn 276.40 Mn
4 Jbs 14.54 Bn 11.07 Bn 4.91 Bn 1.08 Bn
5 Hormel Foods 13.26 Bn 12.40 Bn 518.51 Mn 217.11 Mn
6 J M Smucker 13.17 Bn 13.11 Bn 862.10 Mn 444.50 Mn
7 Magnum Ice Cream 12.10 Bn 11.38 Bn - -
8 Darling Ingredients 10.78 Bn 10.62 Bn 503.37 Mn 555.24 Mn
9 Smithfield Foods 8.77 Bn 7.42 Bn 478.00 Mn 290.00 Mn
10 Cordyceps Sunshine Biotech Holdings 1.02 Bn 1.02 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2023 120,448.00
Dec 31, 2022 -36,901.00
Dec 31, 2021 -176,212.00